|[[Eli Lilly and Company]]
...' or '''incretin mimetics''', are a class of drugs that reduce blood sugar and [[energy intake]] by activating the [[glucagon-like peptide 1 receptor|GLP-
...
13 KB (1,847 words) - 16:47, 13 April 2024
|[[Eli Lilly and Company]]
...' or '''incretin mimetics''', are a class of drugs that reduce blood sugar and [[energy intake]] by activating the [[glucagon-like peptide 1 receptor|GLP-
...
14 KB (1,899 words) - 16:46, 13 April 2024
...tty acid—and to synthesize and metabolize [[protein]]s, [[carbohydrate]]s, and [[fat]]s.
...e, and hence makes for longer product shelf-life, than sodium pantothenate and free pantothenic acid.
...
19 KB (2,673 words) - 17:36, 20 February 2024
...tty acid—and to synthesize and metabolize [[protein]]s, [[carbohydrate]]s, and [[fat]]s.
...e, and hence makes for longer product shelf-life, than sodium pantothenate and free pantothenic acid.
...
19 KB (2,739 words) - 17:33, 20 February 2024
...GLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[gluco
...that was approved by the FDA, being accepted in March 2013. Dapagliflozin and empagliflozin were accepted in 2014.
...
17 KB (2,477 words) - 09:56, 14 February 2024
<!-- Chemical and physical data -->
...lity = Practically insoluble in water, freely soluble in ethanol, methanol and some other organic solvents. Slightly soluble in vegetable oils.
...
18 KB (2,635 words) - 21:30, 11 April 2024
...GLT-2 inhibitors. The efficacy of the drug is dependent on renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[gluco
...that was approved by the FDA, being accepted in March 2013. Dapagliflozin and empagliflozin were accepted in 2014.
...
17 KB (2,553 words) - 09:56, 14 February 2024
<!-- Chemical and physical data -->
...lity = Practically insoluble in water, freely soluble in ethanol, methanol and some other organic solvents. Slightly soluble in vegetable oils.
...
18 KB (2,713 words) - 21:28, 11 April 2024
...s to store [[energy]] in the form of [[lipid]]s, although it also cushions and [[Thermal insulation|insulates]] the body.
...tion of diseases including [[type 2 diabetes]], [[cardiovascular disease]] and [[atherosclerosis]].
...
31 KB (4,635 words) - 14:46, 27 February 2024
...s to store [[energy]] in the form of [[lipid]]s, although it also cushions and [[Thermal insulation|insulates]] the body.
...tion of diseases including [[type 2 diabetes]], [[cardiovascular disease]] and [[atherosclerosis]].
...
32 KB (4,755 words) - 14:46, 27 February 2024
...ase [[body weight]], or to prevent and treat diseases such as [[diabetes]] and [[obesity]]. As weight loss depends on [[calorie]] intake, [[List of diets|
...ts attempt to lose weight through dieting, including 66.7% of obese adults and 26.5% of normal weight or underweight adults. Dieters who are [[overweight]
...
24 KB (3,606 words) - 15:52, 8 March 2024
{{Redirect2|Veggie|Veg|the diet that abstains from animal products and consists mostly of plants|:en:Veganism|a vegetarian diet|:en:Vegetarianism|
...such as [[tomato]]es and [[courgette]]s, [[flower]]s such as [[broccoli]], and seeds such as [[Pulse (legume)|pulses]].
...
29 KB (4,167 words) - 08:08, 23 January 2023
...ase [[body weight]], or to prevent and treat diseases such as [[diabetes]] and [[obesity]]. As weight loss depends on [[calorie]] intake, [[List of diets|
...ts attempt to lose weight through dieting, including 66.7% of obese adults and 26.5% of normal weight or underweight adults. Dieters who are [[overweight]
...
25 KB (3,704 words) - 15:51, 8 March 2024
| causes = Accumulation of saturated fats, smoking, high blood pressure and diabetes
<!-- Definition and symptoms -->
...
44 KB (6,247 words) - 22:10, 5 March 2024
| causes = Accumulation of saturated fats, smoking, high blood pressure and diabetes
<!-- Definition and symptoms -->
...
45 KB (6,411 words) - 22:09, 5 March 2024
{{Short description|Type of diabetes mellitus with high blood sugar and insulin resistance}}
<!-- Definition and symptoms -->
...
37 KB (5,380 words) - 09:55, 19 February 2024
{{Short description|Type of diabetes mellitus with high blood sugar and insulin resistance}}
<!-- Definition and symptoms -->
...
38 KB (5,508 words) - 09:55, 19 February 2024
...nt compounds in this group are vitamin D<sub>3</sub> ([[cholecalciferol]]) and vitamin D<sub>2</sub> ([[ergocalciferol]]).
...in D is taken by mouth, because sun exposure in the population is variable and recommendations about the amount of sun exposure that is safe are uncertain
...
61 KB (8,956 words) - 20:04, 4 February 2024
...nt compounds in this group are vitamin D<sub>3</sub> ([[cholecalciferol]]) and vitamin D<sub>2</sub> ([[ergocalciferol]]).
...in D is taken by mouth, because sun exposure in the population is variable and recommendations about the amount of sun exposure that is safe are uncertain
...
63 KB (9,192 words) - 20:03, 4 February 2024
[[File: Insulin chain A and B linked by disulfide bridges.gif|frame|right|Insulin is a peptide hormone
...genesis]], or, in the case of the liver, into both. [[Glucose]] production and [[secretion]] by the liver is strongly inhibited by high concentrations of
...
64 KB (9,275 words) - 16:39, 18 March 2024